Exogenous iron caused osteocyte apoptosis, increased RANKL production, and stimulated bone resorption through oxidative stress in a murine model

• Published in: Chemico-biological interactions 2024-08, Vol.399, p.111135, Article 111135
• Main Authors: Guo, Zengfeng, Wu, Jiawen, Hu, Yawei, Zhou, Jianhua, Li, Qingmei, Zhang, Yandong, Zhang, Junde, Yang, Linbo, Wang, Shenghang, Zhang, Hao, Yang, Jiancheng
• Format: Article
• Language: English
• Subjects: Acetylcysteine - pharmacology; Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis - drug effects; Bone formation; Bone resorption; Bone Resorption - metabolism; Bone Resorption - pathology; Disease Models, Animal; Iron - metabolism; Iron overload; Iron Overload - chemically induced; Iron Overload - metabolism; Iron Overload - pathology; Male; Mice; Mice, Inbred C57BL; Osteocytes; Osteocytes - drug effects; Osteocytes - metabolism; Osteoporosis; Osteoprotegerin - metabolism; Oxidative stress; Oxidative Stress - drug effects; RANK Ligand - metabolism
• ISSN: 0009-2797; 1872-7786; 1872-7786
• DOI: 10.1016/j.cbi.2024.111135

Iron overload is a risk factor for osteoporosis due to its oxidative toxicity. Previous studies have demonstrated that an excessive amount of iron increases osteocyte apoptosis and receptor activator of nuclear factor κ-B ligand (RANKL) production, which stimulates osteoclast differentiation in vitro. However, the effects of exogenous iron supplementation-induced iron overload on osteocytes in vivo and its role in iron overload-induced bone loss are unknown. This work aimed to develop an iron overloaded murine model of C57BL/6 mice by intraperitoneal administration of iron dextran for two months. The iron levels in various organs, bone, and serum, as well as the microstructure and strength of bone, apoptosis of osteocytes, oxidative stress in bone tissue, and bone formation and resorption, were assessed. The results showed that 2 months of exogenous iron supplementation significantly increased iron levels in the liver, spleen, kidney, bone tissue, and serum. Iron overload negatively affected bone microstructure and strength. Osteocyte apoptosis and empty lacunae rate were elevated by exogenous iron. Iron overload upregulated RANKL expression but had no significant impact on osteoprotegerin (OPG) and sclerostin levels. Static and dynamic histologic analyses and serum biochemical assay showed that iron overload increased bone resorption without significantly affecting bone formation. Exogenous iron promoted oxidative stress in osteocytes in vivo and in vitro. Additional supplementation of iron chelator (deferoxamine) or N-acetyl-l-cysteine (NAC) partially alleviated bone loss, osteocyte apoptosis, osteoclast formation, and oxidative stress due to iron overload. These findings, in line with prior in vitro studies, suggest that exogenous iron supplementation induces osteoclastogenesis and osteoporosis by promoting osteocyte apoptosis and RANKL production via oxidative stress. •Exogenous iron-induced osteocyte apoptosis through oxidative stress.•Exogenous iron promoted osteocytic RANKL expression in vivo•Exogenous iron triggered bone resorption without affecting bone formation in vivo